QTXB Projected Dividend Yield
QuantRx Biomedical Corp ( OTCBB : QTXB )QuantRx Biomedical is focused on developing and commercializing its patented miniform pads (PADs) and PAD based over-the-counter products for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses and other medical needs. Co. is also developing and commercializing genomic diagnostics for the laboratory market, based on its lateral flow patents. Co.'s Unique® miniform is available as a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, and as an untreated pad, for the daily protection of light urinary, vaginal or anal leakage. 21 YEAR PERFORMANCE RESULTS |
QTXB Dividend History Detail QTXB Dividend News QTXB Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |